MoneyWorks4Me

Triochem Products - Quaterly Results

28 May 2024 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended March 2024. The figure stood at Rs. 0.00 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 3.24 millions grew from Rs.-1.99 millions Operating profit Margin for the quarter ended March 2024 improved to 4.72% as compared to -2.39% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 8.02 0.72 1013.89 10.30 2.78 270.50 10.30 2.78 270.50
PBIDT 4.72 -2.39 -297.49 -0.83 -10.65 -92.21 -0.83 -10.65 -92.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 4.72 -2.39 -297.49 -12.40 -10.65 16.43 -12.40 -10.65 16.43
Depreciation 0.22 0.26 -15.38 0.90 1.05 -14.29 0.90 1.05 -14.29
PBT 4.50 -2.65 -269.81 -13.30 -11.70 13.68 -13.30 -11.70 13.68
TAX 1.26 -0.66 -290.91 -3.17 -2.85 11.23 -3.17 -2.85 11.23
Deferred Tax 0.07 -0.65 -110.77 -4.35 -2.76 57.61 -4.35 -2.76 57.61
PAT 3.24 -1.99 -262.81 -10.13 -8.85 14.46 -10.13 -8.85 14.46
Equity 2.45 2.45 0.00 2.45 2.45 0.00 2.45 2.45 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..